Biotechnology Archives

6 considerations for scaling up an industrial biotechnology process

Industrial biotechnology processes face a unique set of challenges when it comes to scale-up.

Viral vectors—beyond the yellow brick road

The science of viral vector manufacturing is generating a lot of excitement, and companies in this space are under pressure to move fast and make cost-effective decisions; this can occasionally result in speed at the expense of due diligence.

Vaccines—our best long-term defense

Not a treatment, but a cure, vaccines are extremely important because they help us develop lifelong immunity to diseases.

Multimodal ATMP facilities to satisfy growing demand

Multimodal manufacturing optimizes product combinations based on manufacturing and regulatory similarity and compatibility. Manufacturers must produce a variety of Advanced Therapy Medicinal Products (ATMPs) quickly and efficiently. Why not design a multi-modal ATMP facility?

Three strategies for successful ATMP facility design

Essential strategies to position your ATMP facility for success.

COVID-19 drug development strategies

All eyes are on those on the front lines seeking to develop and produce new drugs. There’s unprecedented pressure to offer both immediate treatments for those affected and long-term biotherapies and vaccines to prevent future epidemics.

Keys to accelerating your COVID-19 drug campaign

As SARS-CoV-2 moves fast through our global population, the pharmaceutical industry faces tremendous pressure to move even faster.

5 considerations for a commercial scale ATMP facility

Commercial scale is not far-off for advanced therapy medicinal product (ATMP) facilities.

How to deliver multi-product ATMP facilities for future flexibility

Manufacturers must produce a variety of ATMPs quickly and efficiently. Enter the multi-product ATMP facility.

Cell and gene therapy facility design molded by commercial biopharma experience

Interview with Niranjan Kulkarni, Senior Director, Allan Bream, Process Specialist, and Grace Linton, Process Architect at CRB that originally appeared in Cell and Gene Therapy Insights, on how commercial biopharma experience is shaping cell and gene therapy facility design.